These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 7586598)

  • 41. The effect of weight loss on inflammation in obese women with polycystic ovary syndrome.
    Olszanecka-Glinianowicz M; Zahorska-Markiewicz B; Kocełak P; Janowska J; Semik-Grabarczyk E
    Endokrynol Pol; 2008; 59(1):13-7. PubMed ID: 18335395
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A preponderance of basic luteinizing hormone (LH) isoforms accompanies inappropriate hypersecretion of both basal and pulsatile LH in adolescents with polycystic ovarian syndrome.
    Ropelato MG; Garcia-Rudaz MC; Castro-Fernandez C; Ulloa-Aguirre A; Escobar ME; Barontini M; Veldhuis JD
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4629-36. PubMed ID: 10599730
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of adiponectin and resistin gene polymorphisms in South Indian women with polycystic ovary syndrome.
    Nambiar V; Vijesh VV; Lakshmanan P; Sukumaran S; Suganthi R
    Eur J Obstet Gynecol Reprod Biol; 2016 May; 200():82-8. PubMed ID: 26995146
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Examination of angiopoietin-like protein 4, neuropeptide Y, omentin-1 levels of obese and non-obese patients with polycystic ovary syndrome.
    Güneş M; Bukan N
    Gynecol Endocrinol; 2015; 31(11):903-6. PubMed ID: 26291814
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lack of linear relationship between hyperinsulinaemia and hyperandrogenism.
    Toscano V; Bianchi P; Balducci R; Guglielmi R; Mangiantini A; Lubrano C; Sciarra F
    Clin Endocrinol (Oxf); 1992 Feb; 36(2):197-202. PubMed ID: 1533185
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Macrophage migration inhibitory factor in obese and non obese women with polycystic ovary syndrome.
    Mejia-Montilla J; Álvarez-Mon M; Reyna-Villasmil E; Torres-Cepeda D; Santos-Bolívar J; Reyna-Villasmil N; Suarez-Torres I; Bravo-Henríquez A
    Endocrinol Nutr; 2015 Jan; 62(1):31-7. PubMed ID: 25458401
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Leptin concentrations in hirsute women with polycystic ovary syndrome or idiopathic hirsutism: influence on LH and relationship with hormonal, metabolic, and anthropometric measurements.
    Spritzer PM; Poy M; Wiltgen D; Mylius LS; Capp E
    Hum Reprod; 2001 Jul; 16(7):1340-6. PubMed ID: 11425810
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Insulin-like factor 3: a new circulating hormone related to luteinizing hormone-dependent ovarian hyperandrogenism in the polycystic ovary syndrome.
    Gambineri A; Patton L; De Iasio R; Palladoro F; Pagotto U; Pasquali R
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2066-73. PubMed ID: 17356050
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence of polycystic ovarian changes and polycystic ovary syndrome in premenopausal women with treated type 2 diabetes mellitus.
    Kelestimur F; Unluhizarci K; Baybuga H; Atmaca H; Bayram F; Sahin Y
    Fertil Steril; 2006 Aug; 86(2):405-10. PubMed ID: 16762349
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical, metabolic and endocrine parameters in response to metformin in obese women with polycystic ovary syndrome: a randomized, double-blind and placebo-controlled trial.
    Chou KH; von Eye Corleta H; Capp E; Spritzer PM
    Horm Metab Res; 2003 Feb; 35(2):86-91. PubMed ID: 12734787
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Monocyte chemoattractant protein-1 and its correlation with lipoprotein in polycystic ovary syndrome].
    Hu WH; Qiao J; Zhao SY; Zhang XW; Li MZ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):487-91. PubMed ID: 17068620
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
    Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
    Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum HLA-G levels in women with polycystic ovary syndrome.
    Oztekin O; Fenkci SM; Fenkci V; Enli Y; Cabus U
    Gynecol Endocrinol; 2015 Mar; 31(3):243-6. PubMed ID: 25403326
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of AR rs6152G/A gene polymorphism with susceptibility to polycystic ovary syndrome in Chinese women.
    Peng CY; Long XY; Lu GX
    Reprod Fertil Dev; 2010; 22(5):881-5. PubMed ID: 20450840
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Elevated serum levels of tumor necrosis factor alpha in normal-weight women with polycystic ovary syndrome.
    Gonzalez F; Thusu K; Abdel-Rahman E; Prabhala A; Tomani M; Dandona P
    Metabolism; 1999 Apr; 48(4):437-41. PubMed ID: 10206434
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Elevated anti-Mullerian hormone in lean women may not indicate polycystic ovarian syndrome.
    Bradbury RA; Lee P; Smith HC
    Aust N Z J Obstet Gynaecol; 2017 Oct; 57(5):552-557. PubMed ID: 28597496
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Common variants in the sex hormone-binding globulin gene (SHBG) and polycystic ovary syndrome (PCOS) in Mediterranean women.
    Martínez-García MÁ; Gambineri A; Alpañés M; Sanchón R; Pasquali R; Escobar-Morreale HF
    Hum Reprod; 2012 Dec; 27(12):3569-76. PubMed ID: 23001781
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Elevated serum levels of free insulin-like growth factor I in polycystic ovary syndrome.
    Thierry van Dessel HJ; Lee PD; Faessen G; Fauser BC; Giudice LC
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3030-5. PubMed ID: 10487660
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of SHBG gene pentanucleotide TAAAA repeat and D327N polymorphism on serum sex hormone-binding globulin concentration in hirsute women.
    Cousin P; Calemard-Michel L; Lejeune H; Raverot G; Yessaad N; Emptoz-Bonneton A; Morel Y; Pugeat M
    J Clin Endocrinol Metab; 2004 Feb; 89(2):917-24. PubMed ID: 14764814
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-Müllerian hormone gene polymorphism is associated with androgen levels in Chinese polycystic ovary syndrome patients with insulin resistance.
    Zheng MX; Li Y; Hu R; Wang FM; Zhang XM; Guan B
    J Assist Reprod Genet; 2016 Feb; 33(2):199-205. PubMed ID: 26732661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.